ADVERTISEMENT
CURRENT ISSUE
MAY 2013
KINDLE EDITION



SEARCH JOURNAL ARCHIVES


SEARCH PUBMED


MANUSCRIPT SUBMISSIONS


SUBSCRIBE TO SLEEP

CONTINUING MEDICAL EDUCATION


ADVERTISE WITH US


ABOUT SLEEP

ABSTRACT SUPPLEMENTS


ACCEPTED PAPERS
Bookmark and Share         RSS Feed

VOLUME 35, ISSUE 01

EFFECTS OF GF-015535-00 ON THE SLEEP-WAKE CYCLE IN MICE
Effects of GF-015535-00, a Novel α1 GABAA Receptor Ligand, on the Sleep-Wake Cycle in Mice, with Reference to Zolpidem

http://dx.doi.org/10.5665/sleep.1596

Christelle Anaclet, PhD; Mei Zhang, MD, PhD; Chunmei Zhao, PhD; Colette Buda, BSc; Laurent Seugnet, PhD; Jian-Sheng Lin, MD, PhD

Integrative Physiology of Brain Arousal Systems, Lyon Neuroscience Research Center, INSERM U1028-CNRS UMR 5292, Faculty of Medicine, Claude Bernard University, Lyon, France



  Expand  Table of Contents    
Text size:  

Study Objectives:

Novel, safe, and efficient hypnotic compounds capable of enhancing physiological sleep are still in great demand in the therapy of insomnia. This study compares the sleep-wake effects of a new α1 GABAA receptor subunit ligand, GF-015535-00, with those of zolpidem, the widely utilized hypnotic compound.

Methods:

Nine C57Bl6/J male mice were chronically implanted with electrodes for EEG and sleep-wake monitoring. Each mouse received 3 doses of GF-015535-00 and zolpidem. Time spent in sleep-wake states and cortical EEG power spectra were analyzed.

Results:

Both zolpidem and GF-015535-00 prominently enhanced slow wave sleep and paradoxical sleep in the mouse. However, as compared with zolpidem, GF-015535-00 showed several important differences: (1) a comparable sleep-enhancing effect was obtained with a 10 fold smaller dose; (2) the induced sleep was less fragmented; (3) the risk of subsequent wake rebound was less prominent; and (4) the cortical EEG power ratio between slow wave sleep and wake was similar to that of natural sleep and thus compatible with physiological sleep.

Conclusion:

The characteristics of the sleep-wake effects of GF-015535-00 in mice could be potentially beneficial for its use as a therapeutic compound in the treatment of insomnia. Further investigations are required to assess whether the same characteristics are conserved in other animal models and humans.

Citation:

Anaclet C; Zhang M; Zhao C; Buda C; Seugnet L; Lin JS. Effects of GF-015535-00, a novel α1 GABAA receptor ligand, on the sleep-wake cycle in mice, with reference to zolpidem. SLEEP 2012;35(1):103-111.

Expand  Table of Contents
ADVERTISEMENT
Classifieds View SLEEP 2011 Poster Presentations Online